ESC 365 - What’s coming next: zalunfiban for primary PCI in STEMI

ACVC Premium Access

What’s coming next: zalunfiban for primary PCI in STEMI

Session: State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?

Topic: Pharmacotherapy

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Event: ESC Acute CardioVascular Care 2025

Congress Presentation

Add to my library

About the speaker

Professor Uwe Zeymer

Foundation Institute for Heart Attack Research, Ludwigshafen (Germany)

21 presentations

3 followers

6 more presentations in this session

How to approach periprocedural antithrombotic treatment

Speaker: Professor I. Ahrens (Cologne, DE)

How to individualise antiplatelet therapy: from DAPT shortening to de-escalation

Speaker: Professor P. Vranckx (Hasselt, BE)

How to adapt antithrombotic treatment in specific clinical scenarios

Speaker: Associate Professor S. Leonardi (Pavia, IT)

Antiplatelet strategies in acute myocardial infarction cardiogenic shock (AMICS)

Speaker: Doctor S. Gorgis (Detroit, US)

State-of-the-art antithrombotic treatment in acute coronary syndromes - discussion

Access the full session

State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?

Speakers: Professor U. Zeymer, Professor I. Ahrens, Professor P. Vranckx, Associate Professor S. Leonardi, Doctor S. Gorgis

About the event

ESC Acute CardioVascular Care 2025

14 March - 15 March 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources